Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) EBT (2017 - 2020)

enVVeno Medical has reported EBT over the past 4 years, most recently at -$4.2 million for Q4 2020.

  • Quarterly results put EBT at -$4.2 million for Q4 2020, down 80.88% from a year ago — trailing twelve months through Dec 2020 was -$9.1 million (down 19.02% YoY), and the annual figure for FY2025 was -$20.2 million, up 13.78%.
  • EBT for Q4 2020 was -$4.2 million at enVVeno Medical, down from -$1.9 million in the prior quarter.
  • Over the last five years, EBT for NVNO hit a ceiling of -$1.2 million in Q2 2017 and a floor of -$4.2 million in Q4 2020.
  • Median EBT over the past 4 years was -$1.8 million (2017), compared with a mean of -$2.0 million.
  • Biggest five-year swings in EBT: plummeted 152.63% in 2018 and later soared 37.02% in 2019.
  • enVVeno Medical's EBT stood at -$1.9 million in 2017, then grew by 6.73% to -$1.8 million in 2018, then dropped by 27.8% to -$2.3 million in 2019, then plummeted by 80.88% to -$4.2 million in 2020.
  • The last three reported values for EBT were -$4.2 million (Q4 2020), -$1.9 million (Q3 2020), and -$1.5 million (Q2 2020) per Business Quant data.